Inhibikase
Inhibikase is a Georgia-based pharmaceutical company that researches and develops small-molecule therapies for the treatment of neurodegenerative diseases.
Business Model:
Revenue: $61.8k
Employees: 2-10
Rankings
Industries / Tags:
Detailed Inhibikase Information
Geographic Data
Address: 3350 Riverwood Parkway
City: Atlanta
State: GA
Zip: 30339
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$10M
Raised Total:$11M
Social
Metrics
5,277,200Website Global Rank
1,713Website Monthly Traffic
Twitter Followers
Description
Inhibikase is a Georgia-based pharmaceutical company that researches and develops small-molecule therapies for the treatment of neurodegenerative diseases.
Contact Phone:
+16783923419
Contact Email:
Inhibikase went public on 12/22/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
12/22/2020
IPO Valuation:
$101M
Ticker Symbol:
IKT
IPO Price:
$10/share
Amount Raised:
$18M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
